Oncotelic Therapeutics, Inc. (OTLC) Total liabilities 2021–2024
Oncotelic Therapeutics, Inc. (OTLC) total liabilities at each fiscal year-end, per SEC filings.
$18.4MFY2024 · since FY2021: $11.9M → $18.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $18.4M | — |
| FY2021 | $11.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More OTLC financial trends
OTLC RevenueOTLC Net incomeOTLC Net marginOTLC Gross profitOTLC Gross marginOTLC Operating incomeOTLC Operating marginOTLC Operating cash flowOTLC Free cash flowOTLC Capital expendituresOTLC Return on equityOTLC Stock buybacksOTLC Dividends paidOTLC Total assetsOTLC Shareholders’ equityOTLC overview →